0 results available. Select is focused ,type to refine list, press Down to open the menu,
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...
The following section summarizes insights on GSK plc DRC's Other Receivables:
We've identified the following companies as similar to GSK plc DRC because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Other Receivables in the financials category include:
This item represents all amounts receivable by the company in the form of cash other than those classified as accounts receivable or notes receivable.
GSK reported other receivables of 1.258 B for the latest quarter ending December 31, 2024 on its balance sheet.
The tables below summarizes GSK’s Other Receivables and common size over the last five years:
| Fiscal Year | Other Receivables | Assets | % Assets |
|---|---|---|---|
| 2020-12-31 | 1.781 B | 110 B | 1.6% |
| 2021-12-31 | 1.642 B | 107 B | 1.5% |
| 2022-12-31 | 1.171 B | 72.709 B | 1.6% |
| 2023-12-31 | 1.378 B | 75.22 B | 1.8% |
| 2024-12-31 | 1.258 B | 74.446 B | 1.7% |
The tables below summarizes GSK’s Other Receivables and common size over the last four quarters:
| Quarter Ending | Other Receivables | Assets | % Assets |
|---|---|---|---|
| 2024-03-31 | 580.5 M | 73.834 B | 0.8% |
| 2024-06-30 | 656.1 M | 73.402 B | 0.9% |
| 2024-09-30 | 647.1 M | 77.611 B | 0.8% |
| 2024-12-31 | 1.258 B | 74.446 B | 1.7% |
The chart above depicts the distribution of other receivables for companies operating in the Healthcare sector in the Developed economic region. Over 1,230 companies were considered in this analysis, and 1,185 had meaningful values. The average other receivables of companies in the sector is 14.253 M with a standard deviation of 56.068 M.
GSK plc DRC's Other Receivables of 1.258 B is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,235 |
| Included Constituents | 1,185 |
| Min | 3.932 K |
| Max | 719 M |
| Median | 815.104 K |
| Mean | 14.253 M |
| Standard Deviation | 56.068 M |
You can find companies with similar other receivables using this stock screener.